Haohai Biological Tech to Get 80 Million Yuan After Ending Plans to Buy Hengtai Vision

MT Newswires Live

08/21

Shanghai Haohai Biological Technology (HKG:6826, SHA:688366) expects to receive 80 million yuan in compensation after agreeing to terminate plans to acquire Shanghai Hengtai Vision Technology, according to a Shanghai bourse filing on Thursday.

The termination came in the wake of Carl Zeiss Vision International's plan to take over 100% of related company Hengtai Optical.

Moreover, Haohai Biological Tech will terminate the agreement to become the exclusive distributor of Hengtai Vision's orthokeratology rigid gas permeable contact lens product in mainland China.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2561467622"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2561467622\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2561467622?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-21 20:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2561467622","market":"hk","top_or_hot":-1,"title":"Haohai Biological Tech to Get 80 Million Yuan After Ending Plans to Buy Hengtai Vision","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/SHBTF\">Shanghai Haohai Biological</a> Technology (HKG:6826, SHA:688366) expects to receive 80 million yuan in compensation after agreeing to terminate plans to acquire Shanghai Hengtai Vision Technology, according to a Shanghai bourse filing on Thursday.</p><p>The termination came in the wake of Carl Zeiss Vision International's plan to take over 100% of related company Hengtai Optical.</p><p>Moreover, Haohai Biological Tech will terminate the agreement to become the exclusive distributor of Hengtai Vision's orthokeratology rigid gas permeable contact lens product in mainland China.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Haohai Biological Tech to Get 80 Million Yuan After Ending Plans to Buy Hengtai Vision</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHaohai Biological Tech to Get 80 Million Yuan After Ending Plans to Buy Hengtai Vision\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-08-21 20:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/SHBTF\">Shanghai Haohai Biological</a> Technology (HKG:6826, SHA:688366) expects to receive 80 million yuan in compensation after agreeing to terminate plans to acquire Shanghai Hengtai Vision Technology, according to a Shanghai bourse filing on Thursday.</p><p>The termination came in the wake of Carl Zeiss Vision International's plan to take over 100% of related company Hengtai Optical.</p><p>Moreover, Haohai Biological Tech will terminate the agreement to become the exclusive distributor of Hengtai Vision's orthokeratology rigid gas permeable contact lens product in mainland China.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2561467622","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2561467622","pubTimestamp":1755777678,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shanghai Haohai Biological Technology  expects to receive 80 million yuan in compensation after agreeing to terminate plans to acquire Shanghai Hengtai Vision Technology, according to a Shanghai bourse filing on Thursday.The termination came in the wake of Carl Zeiss Vision International's plan to take over 100% of related company Hengtai Optical.Moreover, Haohai Biological Tech will terminate the agreement to become the exclusive distributor of Hengtai Vision's orthokeratology rigid gas permeable contact lens product in mainland China.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688366":"昊海生科","BK1161":"生物科技","BK1593":"医美概念股","06826":"昊海生物科技","BK0251":"专用设备","BK0239":"医药制造"},"translate_title":"昊海生科终止收购恒泰视界计划后将获得8000万元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688366":0.9,"06826":0.9},"content_text":"Shanghai Haohai Biological Technology (HKG:6826, SHA:688366) expects to receive 80 million yuan in compensation after agreeing to terminate plans to acquire Shanghai Hengtai Vision Technology, according to a Shanghai bourse filing on Thursday.The termination came in the wake of Carl Zeiss Vision International's plan to take over 100% of related company Hengtai Optical.Moreover, Haohai Biological Tech will terminate the agreement to become the exclusive distributor of Hengtai Vision's orthokeratology rigid gas permeable contact lens product in mainland China.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}